Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunolo...
Q1 2026
May 11, 2026
FY 2025
Mar 2, 2026
Q4 2025
Q3 2025
Nov 10, 2025
Q2 2025
Aug 11, 2025